213 related articles for article (PubMed ID: 18822329)
1. Alloantigen-induced regulatory CD8+CD103+ T cells.
Koch SD; Uss E; van Lier RA; ten Berge IJ
Hum Immunol; 2008 Nov; 69(11):737-44. PubMed ID: 18822329
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin enhances the number of alloantigen-induced human CD103+CD8+ regulatory T cells in vitro.
Uss E; Yong SL; Hooibrink B; van Lier RA; ten Berge IJ
Transplantation; 2007 Apr; 83(8):1098-106. PubMed ID: 17452901
[TBL] [Abstract][Full Text] [Related]
3. CD8(+)CD103(+) regulatory T cells in spontaneous tolerance of liver allografts.
Lu L; Yu Y; Li G; Pu L; Zhang F; Zheng S; Wang X
Int Immunopharmacol; 2009 May; 9(5):546-8. PubMed ID: 19539566
[TBL] [Abstract][Full Text] [Related]
4. The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL.
Hadley GA; Bartlett ST; Via CS; Rostapshova EA; Moainie S
J Immunol; 1997 Oct; 159(8):3748-56. PubMed ID: 9378961
[TBL] [Abstract][Full Text] [Related]
5. Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer.
Webb JR; Wick DA; Nielsen JS; Tran E; Milne K; McMurtrie E; Nelson BH
Gynecol Oncol; 2010 Sep; 118(3):228-36. PubMed ID: 20541243
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD103 identifies human regulatory T-cell subsets.
Allakhverdi Z; Fitzpatrick D; Boisvert A; Baba N; Bouguermouh S; Sarfati M; Delespesse G
J Allergy Clin Immunol; 2006 Dec; 118(6):1342-9. PubMed ID: 17137867
[TBL] [Abstract][Full Text] [Related]
7. CD103 is a marker for alloantigen-induced regulatory CD8+ T cells.
Uss E; Rowshani AT; Hooibrink B; Lardy NM; van Lier RA; ten Berge IJ
J Immunol; 2006 Sep; 177(5):2775-83. PubMed ID: 16920912
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases.
Braun RK; Foerster M; Grahmann PR; Haefner D; Workalemahu G; Kroegel C
Cytometry B Clin Cytom; 2003 Jul; 54(1):19-27. PubMed ID: 12827664
[TBL] [Abstract][Full Text] [Related]
9. Activated CD4+ CD25+ T cells suppress antigen-specific CD4+ and CD8+ T cells but induce a suppressive phenotype only in CD4+ T cells.
Dieckmann D; Plöttner H; Dotterweich S; Schuler G
Immunology; 2005 Jul; 115(3):305-14. PubMed ID: 15946248
[TBL] [Abstract][Full Text] [Related]
10. CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance.
Keino H; Masli S; Sasaki S; Streilein JW; Stein-Streilein J
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1533-42. PubMed ID: 16565389
[TBL] [Abstract][Full Text] [Related]
11. Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells.
Wong WK; Robertson H; Carroll HP; Ali S; Kirby JA
Transplantation; 2003 Feb; 75(4):505-14. PubMed ID: 12605119
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells.
Nikolaeva N; Bemelman FJ; Yong SL; van Lier RA; ten Berge IJ
Transplantation; 2006 Feb; 81(3):445-54. PubMed ID: 16477233
[TBL] [Abstract][Full Text] [Related]
13. Decidual CD8+CD28- T cells express CD103 but not perforin.
Tilburgs T; Scherjon SA; Roelen DL; Claas FH
Hum Immunol; 2009 Feb; 70(2):96-100. PubMed ID: 19150377
[TBL] [Abstract][Full Text] [Related]
14. CCL25/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes.
Ericsson A; Svensson M; Arya A; Agace WW
Eur J Immunol; 2004 Oct; 34(10):2720-9. PubMed ID: 15368288
[TBL] [Abstract][Full Text] [Related]
15. Predominant donor CD103+CD8+ T cell infiltration into the gut epithelium during acute GvHD: a role of gut lymph nodes.
Zhou S; Ueta H; Xu XD; Shi C; Matsuno K
Int Immunol; 2008 Mar; 20(3):385-94. PubMed ID: 18303011
[TBL] [Abstract][Full Text] [Related]
16. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.
Hilchey SP; Bernstein SH
Immunol Invest; 2007; 36(5-6):629-48. PubMed ID: 18161522
[TBL] [Abstract][Full Text] [Related]
17. Induction of CD4(+)CD25(+) T regulatory cells with CD103 depletion.
Zikri NN; Schumer E; Wang JJ; Gaughan A; Hadley GA; Moffatt-Bruce SD
J Surg Res; 2010 Sep; 163(1):162-8. PubMed ID: 20599216
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of CD103 (αEβ7) integrin expression by CD8 T cells in blood as a surrogate marker to predict cervical T cell responses in the female genital tract during HIV infection.
Kiravu A; Gumbi P; Mkhize NN; Olivier A; Denny L; Passmore JA
Clin Immunol; 2011 Nov; 141(2):143-51. PubMed ID: 21778119
[TBL] [Abstract][Full Text] [Related]
19. Anergic CD8+ T cells can persist and function in vivo.
Blish CA; Dillon SR; Farr AG; Fink PJ
J Immunol; 1999 Jul; 163(1):155-64. PubMed ID: 10384112
[TBL] [Abstract][Full Text] [Related]
20. CD8+ suppressor T cells resurrected.
Kapp JA; Bucy RP
Hum Immunol; 2008 Nov; 69(11):715-20. PubMed ID: 18817830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
